Stage 0a Bladder Cancer AJCC v8 Completed Phase 2 Trials for Bacillus calmette-guerin substrain tice live antigen (DB10343)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110521 (Stage 0a Bladder Cancer AJCC v8) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04496219 | Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer | Supportive Care |